Origin Therapeutics Holdings (XCNQ:ORIG) Capital Expenditure : C$0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Origin Therapeutics Holdings's cash flow for capital expenditures for the three months ended in Jun. 2023 was C$0.00 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Jun. 2023 was C$0.00 Mil.

Origin Therapeutics Holdings Capital Expenditure Historical Data

The historical data trend for Origin Therapeutics Holdings's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Capital Expenditure Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

Capital Expenditure

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Capital Expenditure	Get a 7-Day Free Trial				-	-	-	-	-

Origin Therapeutics Holdings Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.